TScan Therapeutics, Inc. (TCRX)
1.01
-0.01
(-0.98%)
USD |
NASDAQ |
Feb 20, 16:00
1.02
+0.01
(+0.99%)
After-Hours: 20:00
TScan Therapeutics Total Liabilities (Quarterly) : 118.20M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| GT Biopharma, Inc. | 1.321M |
| Sutro Biopharma, Inc. | 296.93M |
| Geron Corp. | 318.68M |
| SELLAS Life Sciences Group, Inc. | 5.925M |
| Agios Pharmaceuticals, Inc. | 104.11M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 262.22M |
| Shareholders Equity (Quarterly) | 144.02M |
| Debt to Equity Ratio | 0.6639 |
| Current Ratio | 6.442 |
| Net Debt Paydown Yield | -0.88% |